Leptospirosis
diseaseOn this page
Also known as cane-cutter fevercanicola feverhemorrhagic jaundiceIcterohemorrhagic feverLeptospira caused disease or disorderLeptospira disease or disorderLeptospira infectious diseasemud fevernanukayami feverrice-field feverStuttgart diseaseswamp feverswineherd's diseaseWeil disease
Summary
Leptospirosis (MONDO:0005825) is a disease and 22 clinical trials. Top therapeutic interventions include desmopressin and dexamethasone. A subtype of primary bacterial infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: 1-9 / 1 000 000 (Europe) [Orphanet-validated]
- Phenotypes (HPO): 40
- Clinical trials: 22
Clinical features
Epidemiology
Prevalence records
27 prevalence record(s), Orphanet, top 20 (validated / broadest geography first):
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Annual incidence | 1-9 / 1 000 000 | 0.12 | Europe | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.92 | France | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.12 | Austria | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.12 | Belgium | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.18 | Bulgaria | Validated |
| Annual incidence | 1-9 / 100 000 | 1.13 | Croatia | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.22 | Czech Republic | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.12 | Denmark | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.24 | Estonia | Validated |
| Annual incidence | <1 / 1 000 000 | 0.02 | Finland | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.12 | Germany | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.22 | Greece | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.16 | Hungary | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.36 | Ireland | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.1 | Italy | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.14 | Latvia | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.3 | Lithuania | Validated |
| Annual incidence | <1 / 1 000 000 | 0.04 | Luxembourg | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.42 | Malta | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.36 | Netherlands | Validated |
Signs & symptoms
Clinical features (HPO)
40 HPO clinical features (Orphanet curated; top 40 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0001873 | Thrombocytopenia | Frequent (30-79%) |
| HP:0001945 | Fever | Frequent (30-79%) |
| HP:0002017 | Nausea and vomiting | Frequent (30-79%) |
| HP:0002027 | Abdominal pain | Frequent (30-79%) |
| HP:0002039 | Anorexia | Frequent (30-79%) |
| HP:0002152 | Hyperproteinemia | Frequent (30-79%) |
| HP:0002315 | Headache | Frequent (30-79%) |
| HP:0002615 | Hypotension | Frequent (30-79%) |
| HP:0002829 | Arthralgia | Frequent (30-79%) |
| HP:0003326 | Myalgia | Frequent (30-79%) |
| HP:0008150 | Elevated serum transaminases during infections | Frequent (30-79%) |
| HP:0030953 | Conjunctival hyperemia | Frequent (30-79%) |
| HP:0000952 | Jaundice | Occasional (5-29%) |
| HP:0000988 | Skin rash | Occasional (5-29%) |
| HP:0001287 | Meningitis | Occasional (5-29%) |
| HP:0001919 | Acute kidney injury | Occasional (5-29%) |
| HP:0002011 | Morphological central nervous system abnormality | Occasional (5-29%) |
| HP:0002014 | Diarrhea | Occasional (5-29%) |
| HP:0002098 | Respiratory distress | Occasional (5-29%) |
| HP:0002105 | Hemoptysis | Occasional (5-29%) |
| HP:0002202 | Pleural effusion | Occasional (5-29%) |
| HP:0002240 | Hepatomegaly | Occasional (5-29%) |
| HP:0002716 | Lymphadenopathy | Occasional (5-29%) |
| HP:0011705 | First degree atrioventricular block | Occasional (5-29%) |
| HP:0012115 | Hepatitis | Occasional (5-29%) |
| HP:0012735 | Cough | Occasional (5-29%) |
| HP:0025143 | Chills | Occasional (5-29%) |
| HP:0025439 | Pharyngitis | Occasional (5-29%) |
| HP:0031197 | Cellular urinary casts | Occasional (5-29%) |
| HP:0040223 | Pulmonary hemorrhage | Occasional (5-29%) |
| HP:0000554 | Uveitis | Very rare (<1-4%) |
| HP:0000573 | Retinal hemorrhage | Very rare (<1-4%) |
| HP:0001085 | Papilledema | Very rare (<1-4%) |
| HP:0001701 | Pericarditis | Very rare (<1-4%) |
| HP:0003201 | Rhabdomyolysis | Very rare (<1-4%) |
| HP:0011675 | Arrhythmia | Very rare (<1-4%) |
| HP:0011896 | Subconjunctival hemorrhage | Very rare (<1-4%) |
| HP:0012424 | Chorioretinitis | Very rare (<1-4%) |
| HP:0030497 | Macular cotton wool spot | Very rare (<1-4%) |
| HP:0100653 | Optic neuritis | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | leptospirosis |
| Mondo ID | MONDO:0005825 |
| EFO | EFO:0007344 |
| MeSH | D007922 |
| Orphanet | 509 |
| DOID | DOID:2297 |
| ICD-10-CM | A27 |
| ICD-11 | 751399056 |
| NCIT | C84825 |
| SNOMED CT | 77377001 |
| UMLS | C0023364 |
| MedGen | 7309 |
| GARD | 0007881 |
| MedDRA | 10024238 |
| NORD | 1363 |
| Is cancer (heuristic) | no |
Also known as: cane-cutter fever · canicola fever · hemorrhagic jaundice · Icterohemorrhagic fever · Leptospira caused disease or disorder · Leptospira disease or disorder · Leptospira infectious disease · leptospirosis · mud fever · nanukayami fever · rice-field fever · Stuttgart disease · swamp fever · swineherd’s disease · Weil disease
Disease family
This is a subtype of primary bacterial infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › primary bacterial infectious disease › leptospirosis
Related subtypes (36): Buruli ulcer disease, sennetsu fever, salmonellosis, pinta disease, chancroid, gonorrhea, anthrax infection, leprosy, botulism, diphtheria, tetanus, bartonellosis, brucellosis, campylobacteriosis, glanders, granuloma inguinale, legionellosis, listeriosis, Mycobacterium avium complex disease, ornithosis, rhinoscleroma, staphyloenterotoxemia, syphilis, cholera, ehrlichiosis, melioidosis, tuberculosis, tularemia, plague, Q fever, shigellosis, Lyme disease, relapsing fever, spirillary rat-bite fever, streptobacillary rat-bite fever, Borrelia miyamotoi disease
Subtypes (1): Weil’s disease
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
Drugs indicated for this disease
No approved or late-stage (phase ≥3) drug is indicated for this disease; the following are in earlier-phase trials only.
Earlier-phase candidates (phase 2, investigational — efficacy not yet established): Desmopressin, Dexamethasone.
Clinical trials & evidence
Clinical trials
Clinical trials: 22.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 19 |
| PHASE4 | 1 |
| PHASE2/PHASE3 | 1 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT04211649 | PHASE4 | NOT_YET_RECRUITING | Comparing Two Antibiotic Therapy Periods (3 Versus 7 Days) in Patients With Mild Leptospirosis and Seen at the Hospital in 5 French Overseas Departments (Martinique, Guadeloupe, French Guiana, Reunion, Mayotte) |
| NCT00592566 | PHASE2/PHASE3 | TERMINATED | Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis |
| NCT07127718 | PHASE2 | RECRUITING | Preventive Strategies for Early and Late Complications of Leptospirosis |
| NCT04034550 | Not specified | ACTIVE_NOT_RECRUITING | Cohort of Hospitalized Patients Suspected of Leptospirosis |
| NCT04288674 | Not specified | RECRUITING | Leptospirosis Registry - LeptoScope |
| NCT05425524 | Not specified | RECRUITING | Leptospirosis Care Bundle Study |
| NCT05436756 | Not specified | RECRUITING | Chronic Post-leptospirosis Manifestations in Reunion |
| NCT06859619 | Not specified | NOT_YET_RECRUITING | Serological Measurement of Montpellier Professionals’ Contacts with Infectious Agents Responsible for Animal-borne Diseases |
| NCT06945822 | Not specified | NOT_YET_RECRUITING | Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI |
| NCT07358910 | Not specified | RECRUITING | Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective |
| NCT07520279 | Not specified | ENROLLING_BY_INVITATION | Xpert® Tropical Fever Test on GeneXpert® Edge X System |
| NCT07611591 | Not specified | NOT_YET_RECRUITING | Ex Vivo Study of Leukocyte Responses in the Blood of Patients With Leptospirosis and ex Vivo Testing of a New Host-targeted Therapeutic Strategy to Restore Phagocytosis of Leptospira |
| NCT01080989 | Not specified | COMPLETED | The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands |
| NCT01607047 | Not specified | UNKNOWN | French West Indies Leptospirosis Study |
| NCT01766830 | Not specified | COMPLETED | Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) |
| NCT02000635 | Not specified | UNKNOWN | Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique |
| NCT02898519 | Not specified | UNKNOWN | Immune Response After Leptospirosis Infection |
| NCT03497572 | Not specified | COMPLETED | Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine |
| NCT03912506 | Not specified | COMPLETED | Severe Leptospirosis in Non-tropical Areas |
| NCT04882046 | Not specified | UNKNOWN | Study of the Incidence of Jarisch-Herxheimer Reaction in Leptospirosis Patients in New Caledonia |
| NCT05300425 | Not specified | COMPLETED | Seroprevalence of Leptospirosis in Val Müstair, Switzerland |
| NCT05413720 | Not specified | COMPLETED | Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| DESMOPRESSIN | 4 | 1 |
| DEXAMETHASONE | 4 | 1 |
Related Atlas pages
- Drugs: Desmopressin, Dexamethasone